Literature DB >> 10881823

Standard aortic St. Jude valve at 18 years: performance profile and determinants of outcome.

O Lund1, S L Nielsen, H Arildsen, L B Ilkjaer, H K Pilegaard.   

Abstract

BACKGROUND: The standard St. Jude disc valve has been in use for 20 years and remains the dominant mechanical valve of today. With nearly 19 years of follow-up, the present large series could indicate the performance profile and its determinants in the very long term.
METHODS: A detailed follow-up was performed to a maximum of 18.6 years in 694 patients aged 15 to 83 years who undervent aortic valve replacement (AVR) with the standard St. Jude valve during 1980 to 1993. The Cox regression analysis was used to identify independent determinants of outcome in the aortic stenosis (n = 490) and regurgitation (n = 204) groups.
RESULTS: Overall survival was 58%, 39%, and 37% at 10, 15, and 18 years, respectively. Only 12% of deaths (0.60%/ patient-year) were related to the valve with a 15-year freedom of 91%. Embolism (1.18%/patient-year) and anticoagulant-related bleeding (2.24%/patient-year) were the dominant complications with 10-year/15-year freedoms of 90%/80% and 85%/72%, respectively. Only 24% of bleeding events were classified as major. Valve thrombosis occurred in 2 patients (0.04%/patient-year): 1 did not receive vitamin K antagonist treatment and International Normalized Ratio was below target level in the other. There were no mechanical failures. Endocarditis (0.42%/patient-year) and paravalvular leak (0.42%/ patient-year) occurred with 15-year freedoms of 92% and 96%, respectively, with a relation between the latter (but not the former) and preoperative endocarditis in the regurgitation group. Freedom from serious complications (2.33%/patient-year) and all complications joined (4.33%/ patient-year) were 72% and 54%, respectively, at 15 years with a 96% freedom from redo AVR (0.36%/patient-year). Age- and heart-related variables were independent risk factors for mortality, thromboembolism, bleeding, serious complications, and all complications joined. Small valve (19 and 21 mm) adversely affected serious and all complications in the regurgitation group.
CONCLUSIONS: With a follow-up approaching 2 decades and exhibiting a low rate of valve-related deaths, acceptable low thrombogenicity, and absence of mechanical failure, the standard aortic St. Jude disc valve sets the standard for contemporary mechanical valves.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881823     DOI: 10.1016/s0003-4975(00)01191-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Clinical experience with the Bicarbon heart valve prosthesis.

Authors:  Yoshio Misawa; Tsutomu Saito; Hiroaki Konishi; Shin-Ichi Oki; Yuichiro Kaminishi; Yasuhito Sakano; Hideki Morita; Kei Aizawa
Journal:  J Cardiothorac Surg       Date:  2007-01-25       Impact factor: 1.637

2.  Mid-term results of small-sized St. Jude Medical Regent prosthetic valves (21 mm or less) for small aortic annulus.

Authors:  Hiroki Mizoguchi; Masayuki Sakaki; Kazushige Inoue; Takashi Iwata; Keikou Tei; Takuya Miura
Journal:  Heart Vessels       Date:  2012-11-17       Impact factor: 2.037

3.  Pathogenesis of paravalvular leakage as a complication occurring in the late phase after surgery.

Authors:  Fumiaki Kuwabara; Akihiko Usui; Yoshimori Araki; Yuji Narita; Shinichi Mizutani; Hideki Oshima; Yuichi Ueda
Journal:  J Artif Organs       Date:  2011-04-20       Impact factor: 1.731

4.  When and how does nonstructural mechanical prosthetic heart valve dysfunction occur?

Authors:  Yoshio Misawa; Tsutomu Saito; Hiroaki Konishi; Shin-ichi Oki; Yuichiro Kaminishi; Hideki Takahashi; Kei Aizawa; Osamu Kamisawa; Morito Kato; Katsuo Fuse
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-08

5.  Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation.

Authors:  J P A Puvimanasinghe; J J M Takkenberg; M B Edwards; M J C Eijkemans; E W Steyerberg; L A Van Herwerden; K M Taylor; G L Grunkemeier; J D F Habbema; A J J C Bogers
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

6.  Paravalvular leakage causing hemolytic anemia at 8-9 years after mitral valve replacement.

Authors:  Yoshio Misawa; Hiroaki Konishi; Tsutomu Saito; Katsuo Fuse
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-12

7.  Fifteen-year experience with the Bicarbon heart valve prosthesis in a single center.

Authors:  Yoshio Misawa; Arata Muraoka; Shin-ichi Ohki; Kei Aizawa; Koji Kawahito; Tsutomu Saito; Hirotaka Sato; Ippei Takazawa; Soki Kurumisawa; Hirohiko Akutsu; Akira Sugaya
Journal:  J Cardiothorac Surg       Date:  2015-06-28       Impact factor: 1.637

8.  Special report: 26-year durability of a bioprosthesis implanted in a 21-year-old patient.

Authors:  Torulv Holst; Josef Reichert; Peter Haldenwang; Vadim Moustafine; Matthias Bechtel; Justus Strauch; Stephan Knipp
Journal:  Thorac Cardiovasc Surg Rep       Date:  2014-02-27

9.  Early and mid-term outcome in terms of functional and hemodynamic performance of the st. Jude regent 19-mm aortic mechanical prosthesis versus 19-mm carpentier edwards aortic biological prosthesis.

Authors:  Edvin Prifti; Massimo Bonacchi; Fadil Ademaj; Gabriele Giunti; Giampiero Esposito; Arben Baboci; Gani Bajraktari; Altin Veshti; Aurel Demiraj; Vittorio Vanini
Journal:  J Cardiothorac Surg       Date:  2015-11-06       Impact factor: 1.637

10.  Inclusion cylinder method for aortic valve replacement utilising the Ross operation in adults with predominant aortic stenosis - 99% freedom from re-operation on the aortic valve at 15 years.

Authors:  Peter D Skillington; M Mostafa Mokhles; William Wilson; Leeanne Grigg; Marco Larobina; Michael O'Keefe; Johanna Takkenberg
Journal:  Glob Cardiol Sci Pract       Date:  2013-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.